(DE) Deere - Overview
Stock: Tractor, Harvester, Sprayer, Loader, Mower
| Risk 5d forecast | |
|---|---|
| Volatility | 45.1% |
| Relative Tail Risk | -9.71% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.02 |
| Alpha | 20.56 |
| Character TTM | |
|---|---|
| Beta | 0.743 |
| Beta Downside | 0.893 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.59% |
| CAGR/Max DD | 0.86 |
EPS (Earnings per Share)
Revenue
Description: DE Deere January 27, 2026
Deere & Company (NYSE: DE) manufactures and distributes a broad portfolio of equipment across four operating segments: Production & Precision Agriculture, Small Agriculture & Turf, Construction & Forestry, and Financial Services.
The Production & Precision Agriculture segment supplies high-horsepower tractors, harvesters, cotton and sugarcane equipment, and precision-application tools; it accounted for roughly 55 % of FY 2023 consolidated revenue, driven by a 12 % YoY increase in global precision-ag adoption (source: Deere 2023 Form 10-K).
The Small Agriculture & Turf segment offers compact tractors, utility vehicles, and turf-care machinery, contributing about 15 % of FY 2023 revenue. Recent data show a 7 % rise in residential-turf sales in North America, reflecting strong post-pandemic home-improvement spending.
Construction & Forestry equipment generated roughly 25 % of FY 2023 sales, with backhoe loaders and excavators benefiting from a 4 % YoY uplift in U.S. construction spending and a 3 % increase in global forestry output (U.S. Census Bureau, 2024).
Financial Services provides equipment financing, dealer wholesale loans, and extended warranties, delivering an operating margin of ~5 % and supporting dealer inventory turnover in a low-interest-rate environment.
Key macro drivers include rising global farm income (FAO, 2024) that fuels demand for precision-ag technology, and a modest rebound in construction activity tied to infrastructure spending bills in the United States.
For a deeper quantitative dive, explore ValueRay’s proprietary metrics on Deere’s valuation.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 4.81b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.64 > 1.0 |
| NWC/Revenue: 22.81% < 20% (prev 87.01%; Δ -64.20% < -1%) |
| CFO/TA 0.07 > 3% & CFO 7.70b > Net Income 4.81b |
| Net Debt (7.59b) to EBITDA (10.94b): 0.69 < 3 |
| Current Ratio: 1.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (270.9m) vs 12m ago -0.51% < -2% |
| Gross Margin: 35.64% > 18% (prev 0.39%; Δ 3525 % > 0.5%) |
| Asset Turnover: 44.55% > 50% (prev 45.51%; Δ -0.96% > 0%) |
| Interest Coverage Ratio: 2.52 > 6 (EBITDA TTM 10.94b / Interest Expense TTM 3.06b) |
Altman Z'' 3.90
| A: 0.10 (Total Current Assets 24.89b - Total Current Liabilities 14.39b) / Total Assets 103.44b |
| B: 0.58 (Retained Earnings 59.68b / Total Assets 103.44b) |
| C: 0.07 (EBIT TTM 7.70b / Avg Total Assets 103.28b) |
| D: 0.81 (Book Value of Equity 62.31b / Total Liabilities 77.08b) |
| Altman-Z'' Score: 3.90 = AA |
Beneish M -1.24
| DSRI: 0.15 (Receivables 8.40b/57.56b, Revenue 46.01b/46.93b) |
| GMI: 1.08 (GM 35.64% / 38.51%) |
| AQI: 5.14 (AQ_t 0.68 / AQ_t-1 0.13) |
| SGI: 0.98 (Revenue 46.01b / 46.93b) |
| TATA: -0.03 (NI 4.81b - CFO 7.70b) / TA 103.44b) |
| Beneish M-Score: -1.24 (Cap -4..+1) = D |
What is the price of DE shares?
Over the past week, the price has changed by +9.88%, over one month by +30.24%, over three months by +39.56% and over the past year by +35.45%.
Is DE a buy, sell or hold?
- StrongBuy: 5
- Buy: 5
- Hold: 14
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the DE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 556.5 | -16% |
| Analysts Target Price | 556.5 | -16% |
DE Fundamental Data Overview February 21, 2026
P/E Forward = 35.9712
P/S = 3.9329
P/B = 6.2981
P/EG = 1.9122
Revenue TTM = 46.01b USD
EBIT TTM = 7.70b USD
EBITDA TTM = 10.94b USD
Long Term Debt = 43.54b USD (from longTermDebt, last fiscal year)
Short Term Debt = 14.39b USD (from shortTermDebt, last quarter)
Debt = 14.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.59b USD (from netDebt column, last quarter)
Enterprise Value = 185.65b USD (179.45b + Debt 14.39b - CCE 8.20b)
Interest Coverage Ratio = 2.52 (Ebit TTM 7.70b / Interest Expense TTM 3.06b)
EV/FCF = 51.91x (Enterprise Value 185.65b / FCF TTM 3.58b)
FCF Yield = 1.93% (FCF TTM 3.58b / Enterprise Value 185.65b)
FCF Margin = 7.77% (FCF TTM 3.58b / Revenue TTM 46.01b)
Net Margin = 10.46% (Net Income TTM 4.81b / Revenue TTM 46.01b)
Gross Margin = 35.64% ((Revenue TTM 46.01b - Cost of Revenue TTM 29.61b) / Revenue TTM)
Gross Margin QoQ = 34.66% (prev 32.57%)
Tobins Q-Ratio = 1.79 (Enterprise Value 185.65b / Total Assets 103.44b)
Interest Expense / Debt = 5.00% (Interest Expense 719.0m / Debt 14.39b)
Taxrate = 23.03% (196.0m / 851.0m)
NOPAT = 5.93b (EBIT 7.70b * (1 - 23.03%))
Current Ratio = 1.73 (Total Current Assets 24.89b / Total Current Liabilities 14.39b)
Debt / Equity = 0.55 (Debt 14.39b / totalStockholderEquity, last quarter 26.30b)
Debt / EBITDA = 0.69 (Net Debt 7.59b / EBITDA 10.94b)
Debt / FCF = 2.12 (Net Debt 7.59b / FCF TTM 3.58b)
Total Stockholder Equity = 25.43b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.66% (Net Income 4.81b / Total Assets 103.44b)
RoE = 18.93% (Net Income TTM 4.81b / Total Stockholder Equity 25.43b)
RoCE = 11.17% (EBIT 7.70b / Capital Employed (Equity 25.43b + L.T.Debt 43.54b))
RoIC = 6.53% (NOPAT 5.93b / Invested Capital 90.73b)
WACC = 8.29% (E(179.45b)/V(193.84b) * Re(8.65%) + D(14.39b)/V(193.84b) * Rd(5.00%) * (1-Tc(0.23)))
Discount Rate = 8.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.49%
[DCF Debug] Terminal Value 80.31% ; FCFF base≈3.84b ; Y1≈4.73b ; Y5≈8.06b
Fair Price DCF = 446.4 (EV 128.60b - Net Debt 7.59b = Equity 121.00b / Shares 271.1m; r=8.29% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -68.22 | EPS CAGR: -24.11% | SUE: 0.77 | # QB: 0
Revenue Correlation: -59.46 | Revenue CAGR: -7.41% | SUE: 0.94 | # QB: 2
EPS next Quarter (2026-04-30): EPS=5.79 | Chg30d=+0.206 | Revisions Net=+0 | Analysts=11
EPS current Year (2026-10-31): EPS=17.16 | Chg30d=+0.499 | Revisions Net=+0 | Growth EPS=-7.2% | Growth Revenue=+3.3%
EPS next Year (2027-10-31): EPS=22.23 | Chg30d=+0.141 | Revisions Net=-3 | Growth EPS=+29.6% | Growth Revenue=+9.1%